Coste J
Laboratoire R&D sécurité transfusionnelle et innovation diagnostique (TransDiag), établissement français du sang de Pyrénées-Méditerranée, 392, avenue du Professeur-Jean-Louis-Viala, 34184 Montpellier cedex 3, France.
Transfus Clin Biol. 2013 Sep;20(4):412-5. doi: 10.1016/j.tracli.2013.04.110. Epub 2013 Aug 6.
Prions are unconventional infectious agents that cause fatal neurological illnesses such as Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy, and scrapie. Variant CJD can occur via blood transfusions. However, as no screening assay is available, uncertainties remain over the prevalence of vCJD in asymptomatic blood donors. Development of a diagnostic assay is therefore a primary objective. Little is known about the nature, distribution and level of infectivity in human blood and we have to rely on assumptions made from animal models. Ideally, two types of assays are required: a rapid high-throughput assay to routinely screen all blood donations and a confirmatory assay to ensure that all positive results from initial screening are true positives. Key event in prion disease is thought to be the conversion of normal cellular prion protein PrPc to a misfolded aggregated form termed PrP(TSE). This specific characteristic has been exploited to develop some tests.
朊病毒是非常规的传染性病原体,可引发致命的神经疾病,如克雅氏病(CJD)、牛海绵状脑病和羊瘙痒病。变异型克雅氏病可通过输血传播。然而,由于目前尚无筛查检测方法,无症状献血者中变异型克雅氏病的流行情况仍存在不确定性。因此,开发一种诊断检测方法是首要目标。我们对人类血液中传染性病原体的性质、分布和感染水平了解甚少,不得不依赖从动物模型得出的假设。理想情况下,需要两种检测方法:一种快速高通量检测方法用于常规筛查所有献血,另一种确证检测方法用于确保初次筛查的所有阳性结果均为真阳性。朊病毒疾病的关键事件被认为是正常细胞朊蛋白PrPc转变为错误折叠的聚集形式,即PrP(TSE)。这一特殊特性已被用于开发一些检测方法。